Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v5-FR | Version v4-EN | |
|---|---|---|
| Language | French | English |
| Date Updated | 2023-08-29 | 2023-08-29 |
| Drug Identification Number | 02431963 | 02431963 |
| Brand name | RIXUBIS | RIXUBIS |
| Common or Proper name | Recombinant Coagulation Factor IX (rFIX) | Recombinant Coagulation Factor IX (rFIX) |
| Company Name | TAKEDA CANADA INC | TAKEDA CANADA INC |
| Ingredients | NONACOG GAMMA | NONACOG GAMMA |
| Strength(s) | 3000UNIT | 3000UNIT |
| Dosage form(s) | POWDER FOR SOLUTION KIT | POWDER FOR SOLUTION KIT |
| Route of administration | INTRAVENOUS INTRAVENOUS | INTRAVENOUS INTRAVENOUS |
| Packaging size | 5 mL Vial | 5 mL Vial |
| ATC code | B02BD | B02BD |
| ATC description | VITAMIN K AND OTHER HEMOSTATICS | VITAMIN K AND OTHER HEMOSTATICS |
| Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
| Anticipated start date | 2023-07-13 | 2023-07-13 |
| Actual start date | 2023-07-13 | 2023-07-13 |
| Estimated end date | 2023-08-31 | 2023-08-31 |
| Actual end date | 2023-08-28 | 2023-08-28 |
| Shortage status | Resolved | Resolved |
| Tier 3 Status | No | No |
| Company comments | Possible complaints on BAXJECT II Transfer Device co-packaged with RIXUBIS drug product | Possible complaints on BAXJECT II Transfer Device co-packaged with RIXUBIS drug product |
| Health Canada comments |